Special Issue "Skin Cancer"

A special issue of Cosmetics (ISSN 2079-9284).

Deadline for manuscript submissions: closed (31 March 2018)

Special Issue Editor

Guest Editor
Dr. Mun Kyung Hwang

Massachusetts Institute of Technology, Cambridge, MA, USA
Website | E-Mail
Interests: skin cancer and chemoprevention; cancer therapeutics; checkpoint kinase signaling; cancer cell migration; cancer therapy resistance

Special Issue Information

Dear Colleagues,

Skin cancer is the most commonly-diagnosed cancer. There are three main types of skin cancers, basal cell and squamous cell carcinomas, which are highly curable if found and treated early, and melanoma, the third-most-common type, accounting for about 1% of total skin cancers, and which causes of a majority of skin cancer deaths.

Skin cancer risk varies with skin type, hair and eye color, history of sunburns, and individual’s immune responses. Among many risk factors, overexposure of ultraviolet (UV) light from the sun or from artificial sources, such as tanning beds, is considered as the major cause of skin cancer. Although the incidence rate of skin cancer, particularly melanoma, keeps increasing, most skin cancers are preventable by protecting from UV radiation. Therefore, it is recommended to wear sunscreen products, all year, with broad-spectrum UV protection and high SPF, and other cosmetics, including moisturizers, make-up, and lip screen, are considered as an excellent day-to-day way to protect skin from the sun.

This Special Issus is dedicated to highlighting the potential of cosmetic products, or their ingredients, to prevent or reduce skin cancer development or progression, as well as the biological effects or mechanisms of action of the products.

Dr. Mun Kyung Hwang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cosmetics is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 350 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Anticancer effects
  • Anticancer ingredients
  • Chronic skin inflammation
  • Photo-damage
  • UV radiation
  • Sun protection

Published Papers (1 paper)

View options order results:
result details:
Displaying articles 1-1
Export citation of selected articles as:

Review

Open AccessFeature PaperReview Skin Regenerative and Anti-Cancer Actions of Copper Peptides
Received: 26 March 2018 / Revised: 14 April 2018 / Accepted: 17 April 2018 / Published: 21 April 2018
PDF Full-text (232 KB) | HTML Full-text | XML Full-text
Abstract
Topical remedies capable of protecting skin from damage and supporting its regeneration can improve skin’s health as well as its appearance. Small copper peptides have an excellent safety record and are widely used in cosmetic products. The most studied copper peptide is GHK-Cu
[...] Read more.
Topical remedies capable of protecting skin from damage and supporting its regeneration can improve skin’s health as well as its appearance. Small copper peptides have an excellent safety record and are widely used in cosmetic products. The most studied copper peptide is GHK-Cu (glycyl-L-histidyl-L-lysine), a small copper-binding peptide, naturally present in human plasma. Since its discovery in 1973, in vivo and in vitro studies have shown that GHK-Cu possesses a wealth of health-positive actions including improving wound contraction and epithelization, and increasing the production of growth factors and activity of antioxidant enzymes. Recently, gene expression profiling shed new light on diverse biological actions of GHK-Cu. The present paper discusses evidence of GHK-Cu and other small copper peptides possessing potent anti-cancer properties. Full article
(This article belongs to the Special Issue Skin Cancer)
Back to Top